Degenerative ataxias: Genetics, pathogenesis and animal models

Current Opinion in Neurology

Volumn 10, Issue 4, 1997, Pages 285-290

  Kakizuka, Akira ^a  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; POLYAMINOACID;

ANIMAL MODEL; ATAXIA; CODON; DEGENERATIVE DISEASE; GENETICS; HUMAN; NONHUMAN; PATHOGENESIS; SHORT SURVEY;

EID: 0030747442     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199708000-00002     Document Type: Short Survey

References (50)

1. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH: Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991, 352:77-79.
2. Huntington's Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
3. Orr HT, Chung M-Y, Banfi S, Kwiatkowski TJ Jr, Servadio A, Beaudet AL, McCall AE, Duvick LA, Ranum LPW, Zoghbi HY: Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet 1993, 4:221-226.
4. Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K, Takahashi H, Kondo R, Ishikawa A, Hayashi T et al.: Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nature Genet 1994, 6:9-13.
5. Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, Bundo M, Takeda T, Tadokoro, K, Kondo I, Murayama N et al.: Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nature Genet 1994, 6:14-18.
6. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S, Nishimura M, Akiguchi I et al.: CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genet 1994, 8:221-228.
7. Campuzano V, Montermini L, Moltò MD, Pianese L, Cossée M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A et al.: Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996, 271:1423-1427. The first identification of the intronic triplet expansions in a most common recessive inherited ataxia, Friedreich's ataxia, is presented.
8. Carvajal JJ, Pook MA, dos Santos M, Doudney K, Hillermann R, Minogue S, Williamson R, Hsuan JJ, Chamberlain S: The Friedreich's ataxia gene encodes a novel phosphatidylinositol-4-phosphate 5-kinase. Nature Genet 1996, 14:157-162.
9. Cossée M, Campuzano V, Koutnikova H, Fischbeck K, Mandel J-L, Koenig M, Bidichandani SI, Patel PI, Moltè MD, Cañizares J et al.: Frataxin fracas [Letter]. Nature Genet 1997, 15:337.
10. Chamberlain S, Pook M, Carvajal J, Doudney K, Hillermann R: Frataxin fracas, [Reply]. Nature Genet 1997, 15:338.
11. Smeyers P, Monrós E, Vilchez J, Lopez-Arlandis J, Prieto F, Palau F: A family segregating a Friedreich ataxia phenotype that is not linked to the FRDA locus. Hum Genet 1996, 97:824-828.
12. Pulst S-M, Nechiporuk A, Nechiporuk T, Gispert S, Chen X-N, Lopes-Cendes I, Pearlman S, Starkman S, Orozco-Diaz G, Lunkes A et al.: Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genet 1996, 14:269-276.
13. Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Garnier J-M, Weber C, Mandel J-L, Cancel G, Abbas N, et al.: Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nature Genet 1996, 14:285-291.
14. Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H, Wakisaka A, Tashiro K, Ishida Y, Ikeuchi T et al.: Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nature Genet 1996, 14:277-284. The authors developed a novel strategy to directly clone a gene fragment with an expanded triplet. This strategy may facilitate the cloning of novel triplet expansions in other inherited neurodegenerations as well as in psychiatric diseases.
15. 1A-voltage-dependent calcium channel. Nature Genet 1997, 15:62-69. The first demonstration that a membrane protein, an α subunit of the calcium channel, with the subtle CAG expansions causes a dominant inherited spinocerebellar ataxia, SCA6.
16. 2+ channel gene CACNL1A4. Cell 1996, 87:543-552. This study retrospectively demonstrated that point mutations in the human SCA6 gene produces dominantly inherited neurological disorders with milder phenotypes than SCA6.
17. Fletcher CF, Lutz CM, O'Sullivan TN, Shaughnessy JD Jr, Hawkes R, Frankel WN, Copeland NG, Jenkins NA: Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 1996, 87:607-617. This study retrospectively demonstrated that the loss of functional mutations in the mouse SCA6 gene produces recessive inherited neurological disorders.
18. Doyle J, Ren XJ, Lennon G, Stubbs L: Mutations in the Cacnl1a4 calcium channel gene are associated with seizures, cerebellar degeneration, and ataxia in tottering and leaner mutant mice. Mammalian Genome 1997, 8:113-120.
19. 2+ channel β subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell 1997, 88:385-392.
20. Kohrman DC, Smith MR, Goldin AL, Harris J, Meisler MH: A missense mutation in the sodium channel Scn8a is responsible for cerebellar ataxia in the mouse mutant jolting. J Neurosci 1996, 16:5993-5999.
21. Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A: Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet 1996, 13:196-202. This is the first demonstration that a long stretch of polyglutamines induces apoptosis in cultured cells and in mouse Purkinje cells in vivo, providing a useful system to analyse biochemical and molecular bases of the polyglutamine disease as well as to screen drugs for the treatments.
22. Onodera O, Roses AD, Tsuji S, Vance JM, Strittmatter WJ, Burke JR: Toxicity of expanded polyglutamine-domain proteins in Escherichia coli. FEBS Lett 1996, 399:135-139.
23. Perutz MF: Glutamine repeats and inherited neurodegenerative diseases: molecular aspects. Curr Opin Struct Biol 1996, 6:848-858.
24. Zoghbi HY: The expanding world of ataxins. Nature Genet 1996, 14:237-238.
25. Lorand L: Neurodegenerative diseases and transglutaminase. Proc Natl Acad Sci U S A 1996, 93:14310-14313.
26. Holmes FE, Haynes LW: Superactivation of transglutaminase type 2 without change in enzyme level occurs during progressive neurodegeneration in the mnd mouse mutant. Neurosci Lett 1996, 213:185-188.
27. Cariello L, de Cristofaro T, Zanetti L, Cuomo T, Di Maio L, Campanella G, Rinaldi S, Zanetti P, Di Lauro R, Varrone S: Transglutaminase activity is related to CAG repeat length in patients with Huntington's disease. Hum Genet 1996, 98:633-635.
28. Kahlem P, Terré C, Green H, Djian P: Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system. Proc Natl Acad Sci U S A 1996, 93:14580-14585.
29. Li X-J, Li S-H, Sharp AH, Nucifora FC Jr, Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA: A huntingtin-associated protein enriched in brain with implications for pathology. Nature 1995, 378:398-402.
30. Wanker EE, Rovira C, Scherzinger E, Hasenbank R, Walter S, Tait D, Colicelli J, Lehrach H: HIP-1: a Huntingtin interacting protein isolated by the yeast two-hybrid system. Hum Molec Genet 1996, 6:487-495.
31. Kalchman MA, Koide HB, McCutcheon K, Graham RK, Nichol K, Nishiyama K, Kazemi-Esfarjani P, Lynn FC, Wellington C, Metzler M et al.: HIP1, a human homolog of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nature Genet 1997, 16:44-53.
32. Burke JR, Enghild JJ, Martin ME, Jou Y-S, Myers RM, Roses AD, Vance JM, Strittmatter WJ: Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med 1996, 2:347-350.
33. Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC, Goldberg YP, Gietz RD, Pickart CM, Hayden MR: Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. J Biol Chem 1996, 271:19385-19394.
34. Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM: Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc Natl Acad Sci U S A 1996, 93:5037-5042.
35. Kossy B, Matilla T, Burright EN, Merry DE, Fischbeck KH, Orr HT, Zoghbi HY: Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3 phosphate dehydrogenase. Hum Molec Genet 1996, 5:1311-1318.
36. Ishitani R, Sunaga K, Hirano A, Saunders P, Katsube N, Chuang D-M: Evidence that Glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J Neurochem 1996, 66:928-935.
37. Ishitani R, Kimura M, Sunaga K, Katsube N, Tanaka M, Chuang D-M: An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. J Pharmacol Exp Ther 1996, 278:447-454.
38. Chuang D-M, Ishitani R: A role for GAPDH in apoptosis and neurodegeneration. Nature Med 1996, 2:609-610.
39. Roses AD, Burke JR, Vance JM, Strittmatter WJ: A role for GAPDH in apoptosis and neurodegeneration [Reply]. Nature Med 1996, 2:610.
40. Scorziello A, Meucci O, Florio T, Fattore M, Forloni G, Salmona M, Schettini G: β25-35 alters calcium homeostasis and induces neurotoxicity in cerebellar granule cells. J Neurochem 1996, 66:1995-2003.
41. Rosen A: Huntingtin: new marker along the road to death? Nature Genet 1996, 13:380-382.
42. Lemaigre-Dubreuil Y, Brugg B, Chianale C, Delhaye-Bouchaud N, Mariani J: Over-expression of interleukin-1β-converting enzyme mRNA in staggerer cerebellum. NeuroReport 1996, 7:1777-1780.
43. de Bilbao F, Dubois-Dauphin M: Acute application of an interleukin-1β-converting enzyme-specific inhibitor delays axotomy-induced motoneurone death. NeuroReport 1996, 7:3051-3054.
44. Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, Bromm M, Kazemi-Esfarjani P, Thornberry NA, Vaillancourt JP, Hayden MR: Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet 1996, 13:442-449.
45. Burright EN, Clark HB, Servadio A, Matilla T, Feddersen RM, Yunis WS, Duvick LA, Zoghbi HY, Orr HT: SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 1995, 82:937-948. This study reports the creation of the first animal models with ataxic phenotypes.
46. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP: Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506. The study demonstrates that the expression of the exon 1 of the HD gene with approximately 130 CAG repeats could produce broad neurological phenotypes in mice, again emphasizing the importance of the long polyglutamine stretches in neurodegeneration.
47. Korneluk RG, Narang MA: Anticipating anticipation. Nature Genet 1997, 15:119-120.
48. Mangiarini L, Sathasivam K, Mahal A, Mott R, Seller M, Bates GP: Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nature Genet 1997, 15:197-200. This is the first demonstration of the CAG instabilities in transgenic mice during the transmission and somatic cell divisions. The instabilities, especially in somatic cells, are concomitantly observed with ataxic phenotypes.
49. Gourdon G, Radvanyi F, Lia A-S, Duros C, Blanche M, Abitbol M, Junien C, Hofmann-Radvanyi H: Moderate intergenerational and somatic instability of a 55-CTG repeat in transgenic mice. Nature Genet 1997, 15:190-192.
50. Monckton DG, Coolbaugh MI, Ashizawa KT, Siciliano MJ, Caskey CT: Hypermutable myotonic dystrophy CTG repeats in transgenic mice. Nature Genet 1997, 15:193-196.